List of serched triples

A total of 22252 records found

#19932 middle Confidence
Subject: SETD2_mutation_in_ccRCC (Gene mutation)
is_associated_with
Object: enlarged_tumor_cells (Tumor cells)
Original: SETD2-mutated ccRCC#showed#high-grade transformation with enlarged tumor cells/ voluminous clear cytoplasm/ irregular nuclei/ and prominent nucleoli
🏥 not_specified 🧬 SETD2 📄 PMID: 37976977
#19931 middle Confidence
Subject: SETD2_mutation_in_ccRCC (Gene mutation)
is_associated_with
Object: high_grade_transformation (Tumor progression)
Original: SETD2-mutated ccRCC#showed#high-grade transformation with enlarged tumor cells/ voluminous clear cytoplasm/ irregular nuclei/ and prominent nucleoli
🏥 Prognostic significance 🧬 SETD2 📄 PMID: 37976977
#19930 middle Confidence
Subject: Tumors_with_prominent_nucleoli (Tumor)
had_higher_frequency_of
Object: chromosome_17_abnormalities (Chromosomal abnormalities)
Original: Tumors with neoplastic cells showing prominent nucleoli#had a higher frequency of#chromosome 17 abnormalities
🏥 Prognosis related 📄 PMID: 14608536
#19929 middle Confidence
Subject: electron_microscopy (Electron microscopy)
supports
Object: diagnosis (Diagnostic outcome)
Original: Classic electron microscopic findings#can support#the diagnosis
🏥 diagnosis 📄 PMID: 21053538
#19928 middle Confidence
Subject: key_features (Key Features)
discriminate_between
Object: nephrogenic_adenoma (Benign lesions)
Original: Key features#discriminate between#nephrogenic adenoma-like clear cell adenocarcinoma and nephrogenic adenoma
🏥 diagnosis 📄 PMID: 20060152
#19927 middle Confidence
Subject: key_features (Key Features)
discriminate_between
Object: nephrogenic_adenoma-like_clear_cell_adenocarcinoma (Tumor type)
Original: Key features#discriminate between#nephrogenic adenoma-like clear cell adenocarcinoma and nephrogenic adenoma
🏥 diagnosis 📄 PMID: 20060152
#19926 middle Confidence
Subject: prominent_nucleoli (Nuclear morphology)
are_a_feature_of
Object: atypical_adenomatous_hyperplasia (Adenomatous hyperplasia of the prostate)
Original: Prominent nucleoli#are a feature of#AAH
🏥 diagnosis 📄 PMID: 8875203
#19925 middle Confidence
Subject: vemurafenib (Targeted drugs)
is_considered_for
Object: treatment_of_histiocytic_sarcoma (Treatment Process)
Original: vemurafenib#is considered for#treatment of histiocytic sarcoma
🏥 treat 📄 PMID: 28376906
#19924 middle Confidence
Subject: chronic_lymphoid_leukemia (Tumor type)
is_characterized_by
Object: B-lymphocyte_proliferation (Cellular Processes)
Original: chronic lymphoid leukemia#was characterized by#proliferation of B-lymphocytes
🏥 diagnosis 📄 PMID: 1404856
#19923 middle Confidence
Subject: 375_prostatic_carcinoma_patients (patient)
were_treated_with
Object: radiation_therapy (Radiation therapy)
Original: 375 prostatic carcinoma patients#were treated with#radiation therapy
🏥 treat 📄 PMID: 1399727
#19922 middle Confidence
Subject: enlarged_nucleoli (Organelles)
are
Object: important_cytological_criteria_for_malignant_changes (Diagnostic criteria)
Original: enlarged nucleoli#are#important cytological criteria for defining malignant changes
🏥 Diagnostic significance 📄 PMID: 7524011
#19921 middle Confidence
Subject: GNA11_mutant_tumor (Tumor)
is_associated_with
Object: poorer_disease_specific_survival (Clinical Outcomes)
Original: GNA11-mutant tumors#had#poorer disease-specific survival than wild-type tumors
🏥 Prognosis 🧬 GNA11 📄 PMID: 23887304
#19920 middle Confidence
Subject: CD20 (Differentiation antigen)
is
Object: diagnostic_aid_in_T-cell_lineage_neoplasms (Diagnostic markers)
Original: CD20 positivity#is#a diagnostic aid in neoplasms of T-cell lineage
🏥 diagnosis 🧬 CD20 📄 PMID: 16124163
#19919 middle Confidence
Subject: NAT10 (protein)
may_be
Object: prognostic_marker (Biomarkers)
Original: NAT10#may be#a prognostic marker and potential therapeutic target
🏥 Prognosis 🧬 NAT10 📄 PMID: 24982245
#19918 middle Confidence
Subject: NPM1 (Nucleolar proteins)
facilitates
Object: nucleolar_stress_response (Cellular stress response)
Original: NPM1#facilitates#ribosome biogenesis and nucleolar stress responses
🏥 not_specified 🧬 NPM1 📄 PMID: 39528457
#19917 middle Confidence
Subject: UBA2_knockdown (Genetic intervention)
suppresses
Object: glioma_cell_progression (Tumor progression)
Original: UBA2 knockdown#suppresses#glioma cell progression
🏥 Therapeutic significance 🧬 UBA2 📄 PMID: 38682183
#19916 middle Confidence
Subject: TGFβ (signaling molecule)
promotes
Object: bone_remodeling (Bone remodeling process)
Original: TGFβ#promotes#bone remodeling
🏥 Bone metabolism 🧬 TGFB 📄 PMID: 38812320
#19915 middle Confidence
Subject: SDHD (Protein coding genes)
involved_less_in
Object: SDH_deficient_RCC (Disease phenotype)
Original: Gene alterations#involve less#SDHC/ SDHA/ and SDHD subunits in SDH-deficient RCC
🏥 Diagnostic significance 🧬 SDHC/SDHA/SDHD 📄 PMID: 39083879
#19914 middle Confidence
Subject: SDHA (Protein coding genes)
involved_less_in
Object: SDH_deficient_RCC (Disease phenotype)
Original: Gene alterations#involve less#SDHC/ SDHA/ and SDHD subunits in SDH-deficient RCC
🏥 Diagnostic significance 🧬 SDHC/SDHA/SDHD 📄 PMID: 39083879
#19913 middle Confidence
Subject: SDHC (Protein coding genes)
involved_less_in
Object: SDH_deficient_RCC (Disease phenotype)
Original: Gene alterations#involve less#SDHC/ SDHA/ and SDHD subunits in SDH-deficient RCC
🏥 Diagnostic significance 🧬 SDHC/SDHA/SDHD 📄 PMID: 39083879